{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:33:33Z","timestamp":1787319213307,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00415-025-13170-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:24:32Z","timestamp":1748607872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-0356","authenticated-orcid":false,"given":"Simona","family":"Maccora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicasio","family":"Rini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"11","key":"13170_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1819","volume":"10","author":"E Westerberg","year":"2020","unstructured":"Westerberg E, Punga AR (2020) Epidemiology of myasthenia gravis in Sweden 2006\u20132016. Brain Behav 10(11):e01819. https:\/\/doi.org\/10.1002\/brb3.1819","journal-title":"Brain Behav"},{"issue":"1","key":"13170_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","volume":"26","author":"A Breiner","year":"2016","unstructured":"Breiner A, Widdifield J, Katzberg HD, Barnett C, Bril V, Tu K (2016) Epidemiology of myasthenia gravis in Ontario. Canada Neuromuscul Disord 26(1):41\u201346. https:\/\/doi.org\/10.1016\/j.nmd.2015.10.009","journal-title":"Canada Neuromuscul Disord"},{"issue":"11","key":"13170_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","volume":"19","author":"M Gattellari","year":"2012","unstructured":"Gattellari M, Goumas C, Worthington JM (2012) A national epidemiological study of myasthenia gravis in Australia. Eur J Neurol 19(11):1413\u20131420. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03698.x","journal-title":"Eur J Neurol"},{"issue":"3\u20134","key":"13170_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000487886","volume":"50","author":"I Martinka","year":"2018","unstructured":"Martinka I, Fulova M, Spalekova M, Spalek P (2018) Epidemiology of myasthenia gravis in Slovakia in the years 1977\u20132015. Neuroepidemiology 50(3\u20134):153\u2013159. https:\/\/doi.org\/10.1159\/000487886","journal-title":"Neuroepidemiology"},{"issue":"3","key":"13170_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ene.13535","volume":"25","author":"A Zieda","year":"2018","unstructured":"Zieda A, Ravina K, Glazere I, Pelcere L, Naudina MS, Liepina L, Kamsa I, Kurjane N, Woodhall M, Jacobson L, Leite MI, Tandon K, Kenina V (2018) A nationwide epidemiological study of myasthenia gravis in Latvia. Eur J Neurol 25(3):519\u2013526. https:\/\/doi.org\/10.1111\/ene.13535","journal-title":"Eur J Neurol"},{"issue":"2","key":"13170_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A (2022) Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol 21(2):176\u2013188. https:\/\/doi.org\/10.1016\/S1474-4422(21)00297-0","journal-title":"Lancet Neurol"},{"issue":"Pt 7","key":"13170_CR7","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis. Brain 131(Pt 7):1940\u20131952. https:\/\/doi.org\/10.1093\/brain\/awn092","journal-title":"Brain"},{"key":"13170_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","volume":"284","author":"AI Tsonis","year":"2015","unstructured":"Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Casasnovas Pons C, Pitha J, Jakub\u00edkova M, Hanisch F, Tzartos SJ (2015) MuSK autoantibodies in myasthenia gravis detected by cell based assay\u2013A multinational study. J Neuroimmunol 284:10\u201317. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.04.015","journal-title":"J Neuroimmunol"},{"issue":"8","key":"13170_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archneurol.2012.437","volume":"69","author":"S Jacob","year":"2012","unstructured":"Jacob S, Viegas S, Leite MI, Webster R, Cossins J, Kennett R, Hilton-Jones D, Morgan BP, Vincent A (2012) Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch Neurol 69(8):994\u20131001. https:\/\/doi.org\/10.1001\/archneurol.2012.437","journal-title":"Arch Neurol"},{"issue":"26","key":"13170_CR10","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375(26):2570\u20132581. https:\/\/doi.org\/10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"issue":"1","key":"13170_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0044-1779052","volume":"82","author":"PRDVP Rodrigues","year":"2024","unstructured":"Rodrigues PRDVP, Kay CSK, Ducci RD, Utiumi MAT, Fustes OJH, Werneck LC, Lorenzoni PJ, Scola RH (2024) Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics. Arq Neuropsiquiatr 82(1):1\u20137. https:\/\/doi.org\/10.1055\/s-0044-1779052","journal-title":"Arq Neuropsiquiatr"},{"issue":"9","key":"13170_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mus.1140","volume":"24","author":"AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine","year":"2001","unstructured":"AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine (2001) Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve 24(9):1239\u20131247. https:\/\/doi.org\/10.1002\/mus.1140","journal-title":"Muscle Nerve"},{"issue":"7","key":"13170_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","volume":"16","author":"M Benatar","year":"2006","unstructured":"Benatar M (2006) A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord 16(7):459\u2013467. https:\/\/doi.org\/10.1016\/j.nmd.2006.05.006","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"13170_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.clinph.2013.11.005","volume":"125","author":"L Padua","year":"2014","unstructured":"Padua L, Caliandro P, Di Iasi G, Pazzaglia C, Ciaraffa F, Evoli A (2014) Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 prospective cases. Clin Neurophysiol 125(6):1270\u20131273. https:\/\/doi.org\/10.1016\/j.clinph.2013.11.005","journal-title":"Clin Neurophysiol"},{"issue":"10","key":"13170_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036. https:\/\/doi.org\/10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"issue":"9","key":"13170_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/brainsci13091286","volume":"13","author":"C Vinciguerra","year":"2023","unstructured":"Vinciguerra C, Bevilacqua L, Lupica A, Ginanneschi F, Piscosquito G, Rini N, Rossi A, Barone P, Brighina F, Di Stefano V (2023) Diagnosis and management of seronegative myasthenia gravis: lights and shadows. Brain Sci 13(9):1286. https:\/\/doi.org\/10.3390\/brainsci13091286","journal-title":"Brain Sci"},{"issue":"6","key":"13170_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10072-012-1159-x","volume":"34","author":"HY Feng","year":"2013","unstructured":"Feng HY, Wang HY, Liu WB, He XT, Huang X, Luo CM, Li Y (2013) The high frequency and clinical feature of seronegative myasthenia gravis in Southern China. Neurol Sci 34(6):919\u2013924. https:\/\/doi.org\/10.1007\/s10072-012-1159-x","journal-title":"Neurol Sci"},{"issue":"1","key":"13170_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16022","volume":"31","author":"R Martinez-Harms","year":"2024","unstructured":"Martinez-Harms R, Barnett C, Alcantara M, Bril V (2024) Clinical characteristics and treatment outcomes in patients with double-seronegative myasthenia gravis. Eur J Neurol 31(1):e16022. https:\/\/doi.org\/10.1111\/ene.16022","journal-title":"Eur J Neurol"},{"issue":"9","key":"13170_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","volume":"73","author":"E Cort\u00e9s-Vicente","year":"2016","unstructured":"Cort\u00e9s-Vicente E, Gallardo E, Mart\u00ednez M\u00c1, D\u00edaz-Manera J, Querol L, Rojas-Garc\u00eda R, Illa I (2016) Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin. JAMA Neurol 73(9):1099\u20131104. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2032","journal-title":"JAMA Neurol"},{"issue":"6","key":"13170_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ene.13300","volume":"24","author":"Y Hong","year":"2017","unstructured":"Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF, Gilhus NE, Tzartos SJ (2017) Multiple antibody detection in \u2018seronegative\u2019 myasthenia gravis patients. Eur J Neurol 24(6):844\u2013850. https:\/\/doi.org\/10.1111\/ene.13300","journal-title":"Eur J Neurol"},{"issue":"9","key":"13170_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.clinph.2011.02.026","volume":"122","author":"R Witoonpanich","year":"2011","unstructured":"Witoonpanich R, Dejthevaporn C, Sriphrapradang A, Pulkes T (2011) Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation. Clin Neurophysiol 122(9):1873\u20131877. https:\/\/doi.org\/10.1016\/j.clinph.2011.02.026","journal-title":"Clin Neurophysiol"},{"key":"13170_CR22","first-page":"45","volume":"19","author":"GA Nicholson","year":"1983","unstructured":"Nicholson GA, McLeod JG, Griffiths LR (1983) Comparison of diagnostic tests in myasthenia gravis. Clin Exp Neurol 19:45\u201349","journal-title":"Clin Exp Neurol"},{"issue":"7","key":"13170_CR23","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1007\/s10072-024-07368-0","volume":"45","author":"V Di Stefano","year":"2024","unstructured":"Di Stefano V, Iacono S, Militello M, Leone O, Rispoli MG, Ferri L, Ajdinaj P, Lanza P, Lupica A, Crescimanno G, Monastero R, Di Muzio A, Brighina F (2024) Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patients. Neurol Sci 45(7):3481\u20133494. https:\/\/doi.org\/10.1007\/s10072-024-07368-0","journal-title":"Neurol Sci"},{"issue":"3","key":"13170_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.nmd.2023.01.006","volume":"33","author":"P Harrison","year":"2023","unstructured":"Harrison P, Barton J, Winkel A (2023) Chronic mimics of myasthenia gravis: a retrospective case series. Neuromuscul Disord 33(3):250\u2013256. https:\/\/doi.org\/10.1016\/j.nmd.2023.01.006","journal-title":"Neuromuscul Disord"},{"key":"13170_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1474-7766.2002.00103.x","volume":"2","author":"J Stone","year":"2002","unstructured":"Stone J (2002) Pseudo-ptosis. Pract Neurol 2:364\u2013365","journal-title":"Pract Neurol"},{"issue":"2","key":"13170_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/jcim-2020-0484","volume":"19","author":"M Edavalath","year":"2021","unstructured":"Edavalath M, Kottil S, Hameed F (2021) Psychogenic pseudo-myasthenic ptosis - management with ayurvedic medicines and Smriti meditation. J Complement Integr Med 19(2):481\u2013485. https:\/\/doi.org\/10.1515\/jcim-2020-0484","journal-title":"J Complement Integr Med"},{"issue":"1","key":"13170_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/wnl.58.1.150-a","volume":"58","author":"ME Roberts","year":"2002","unstructured":"Roberts ME, Steiger MJ, Hart IK (2002) Presentation of myasthenia gravis mimicking blepharospasm. Neurology 58(1):150\u2013151. https:\/\/doi.org\/10.1212\/wnl.58.1.150-a","journal-title":"Neurology"},{"issue":"6","key":"13170_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/pn-2024-004148","volume":"24","author":"S El-Wahsh","year":"2024","unstructured":"El-Wahsh S, Fraser C, Vucic S, Reddel S (2024) Neuromuscular junction disorders: mimics and chameleons. Pract Neurol 24(6):467\u2013477. https:\/\/doi.org\/10.1136\/pn-2024-004148","journal-title":"Pract Neurol"},{"issue":"9","key":"13170_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/mds.25472","volume":"28","author":"M Pawlowski","year":"2013","unstructured":"Pawlowski M, Gess B, Evers S (2013) The Babinski-2 sign in hemifacial spasm. Mov Disord 28(9):1298\u20131300. https:\/\/doi.org\/10.1002\/mds.25472","journal-title":"Mov Disord"},{"issue":"12","key":"13170_CR30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S1474-4422(15)00226-4","volume":"14","author":"D Kaski","year":"2015","unstructured":"Kaski D, Bronstein AM, Edwards MJ, Stone J (2015) Cranial functional (psychogenic) movement disorders. Lancet Neurol 14(12):1196\u20131205. https:\/\/doi.org\/10.1016\/S1474-4422(15)00226-4","journal-title":"Lancet Neurol"},{"key":"13170_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-0-08-045031-5.00014-1","volume":"101","author":"B Brais","year":"2011","unstructured":"Brais B (2011) Oculopharyngeal muscular dystrophy. Handb Clin Neurol 101:181\u2013192. https:\/\/doi.org\/10.1016\/B978-0-08-045031-5.00014-1","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"13170_CR32","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/ijms24043730","volume":"24","author":"K Ohno","year":"2023","unstructured":"Ohno K, Ohkawara B, Shen XM, Selcen D, Engel AG (2023) Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes-a comprehensive review. Int J Mol Sci 24(4):3730. https:\/\/doi.org\/10.3390\/ijms24043730","journal-title":"Int J Mol Sci"},{"issue":"8","key":"13170_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362(8):726\u2013738. https:\/\/doi.org\/10.1056\/NEJMra0905750","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13170-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13170-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T09:25:00Z","timestamp":1749893100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13170-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13170"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13170-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This retrospective study was approved by the institutional ethics board (Comitato Etico Locale Palermo 1; ITA-MG; 27\u201327\/11\/2024). The study conforms with The Code of Ethics of the World Medical Association (Declaration of Helsinki).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent to publish was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"433"}}